Attec Biotech
PrivateLast Round
Series A
Extension
Feb 2, 2026
Company Overview
Attec Biotech operates in Healthcare & Life Sciences and is based in Hangzhou. Its latest recorded funding round was a Series A Extension round in February 2026.
Attec Biotech is a biotechnology company that develops protein degradation drugs using autophagy-lysosome targeting chimeras (ATTEC) technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Attec Biotech Comparables
Compare Attec Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AUTOTAC Bio | 88% | |
| Amphista Therapeutics | 84% | |
| PAQ Therapeutics | 84% |
For institutional investors. Book with your work email.
Attec Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Feb 2, 2026 | ||||
| Series A | Aug 1, 2025 | ||||
| VC Round | Jul 18, 2022 |
For institutional investors. Book with your work email.
Attec Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CAS Star | Series A Extension |
| Furong Investment | Series A Extension |
| Ennovation Ventures | Series A Extension |
| HongShan Capital Group (HSG) | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 18, 2022
Led by HongShan Capital Group (HSG).
For institutional investors. Book with your work email.
Attec Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Attec Biotech's valuation, stock price, and market status.
Is Attec Biotech a public or private company?
Attec Biotech is a private company.
What is the current stock price of Attec Biotech?
Attec Biotech is a private company, so its shares have no public market price. Caplight tracks Attec Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Attec Biotech worth (valuation)?
Valuation information for Attec Biotech is not publicly available.
Can I buy Attec Biotech stock?
Attec Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Attec Biotech's last funding round?
Attec Biotech's most recent funding round was Series A Extension on February 2, 2026.
Who are the main investors in Attec Biotech?
Key investors in Attec Biotech include HongShan Capital Group (HSG).
Will Attec Biotech IPO soon?
No public IPO plans have been announced for Attec Biotech.
How can I track Attec Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Attec Biotech's shares on secondary markets.